Yu-Hsyu Su

Title: Innovations of Yu-Hsyu Su in Cancer Research

Introduction

Yu-Hsyu Su is a prominent inventor based in Taipei, Taiwan, known for his significant contributions to cancer research. He holds a total of four patents, showcasing his innovative approach to addressing critical health challenges. His work primarily focuses on developing synthetic peptides that target cancer stem cells, which are crucial in cancer treatment.

Latest Patents

One of Yu-Hsyu Su's latest patents is titled "Cancer stem cell targeting peptide and use thereof." This patent describes a synthetic peptide designed to specifically target cancer stem cells. The peptide consists of an amino acid sequence from SEQ ID NO: 1 to SEQ ID NO: 15. Additionally, the patent includes a composition that combines this synthetic peptide with a therapeutic agent and a pharmaceutically acceptable carrier or diluent. The method outlined in the patent involves establishing an oligopeptide library using a phage expression system, which is then screened to identify peptides that bind specifically to cancer stem cells.

Career Highlights

Throughout his career, Yu-Hsyu Su has worked with notable organizations, including Stresspro Biomedicine Incorporation and the Animal Technology Institute Taiwan. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in cancer therapies.

Collaborations

Yu-Hsyu Su has collaborated with several professionals, including Chin-Kai Chuang and Ming-Yu Chen. These collaborations have contributed to the advancement of his research and the development of innovative solutions in cancer treatment.

Conclusion

Yu-Hsyu Su's work in developing cancer stem cell targeting peptides represents a significant advancement in cancer research. His innovative approach and dedication to improving therapeutic options highlight the importance of continued research in this critical field.